Sanofi’s Dupixent Shows Strong Efficacy in Second Lung Trial
Sanofi’s prescription drug Dupixent showed additional promise in helping patients with a chronic lung disorder breathe better and
2023-11-27 14:47
FDA Weighing What to Do About $900,000 Drug That May Not Work
The cancer drug Folotyn, one of the most expensive in the US, received a short-cut approval from US
2023-11-16 18:52
An Opioid-Like Drink Is Masquerading As a Wholesome Alcohol Alternative
When Krista Marquick discovered kratom, it filled a hole in her life that quitting alcohol had left —
2023-11-10 18:45
New Ozempic Rival Is About to Make Your Weight Loss Drugs Cheaper
An effective and massively popular weight-loss drug has made Novo Nordisk A/S billions of dollars and turned it
2023-11-09 07:27
Eli Lilly Wins FDA Nod for Obesity Drug That Rivals Wegovy, Ozempic
Eli Lilly & Co. won US approval for its diabetes drug to treat obesity, unlocking blockbuster sales potential
2023-11-09 04:23
Sarepta Seeks Broader Approval for Gene Therapy Even After Drug Trial Fizzled
Normally when a drug fails to show a clear effect in a final-stage trial, the company developing it
2023-11-01 05:15
Gene Therapy for Kids’ Deadly Muscle Disease Fails to Reach Trial Goal
Roche Holding AG shares dropped after a trial of its gene therapy for Duchenne muscular dystrophy did not
2023-10-31 16:58
China’s Junshi Nabs FDA Approval in Rare Success for US Foray
The US Food and Drug Administration has cleared the first China-developed cancer drug similar to Merck & Co.’s
2023-10-28 11:15
Verve Surges After FDA Lifts Hold on Gene-Editing Therapy
Verve Therapeutics Inc. surged in premarket trading after US drug regulators lifted their hold on the company’s application
2023-10-23 20:20
GSK Settles Zantac Lawsuit Set for Trial in California
GSK Plc reached a settlement for another US lawsuit claiming the drugmaker’s blockbuster heartburn medication Zantac causes cancer.
2023-10-11 15:46
Bristol Myers to Buy Mirati Therapeutics for $4.8 Billion
Bristol-Myers Squibb Co. has agreed to buy cancer drugmaker Mirati Therapeutics Inc. for $4.8 billion as the company
2023-10-09 09:26
Philips Slumps After Another Blow to Sleep Product Recall
Royal Philips NV suffered another setback as the US drug regulator requested additional tests on its sleep apnea
2023-10-06 16:56